IL6R, Human (Satralizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-IL6R, Human (Satralizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityIL6R, Human (Satralizumab biosimilar)
CloneSatralizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG2 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human IL6R Recombinant Antibody (Satralizumab). Satralizumab, sold under the brand name Enspryng, is a humanized monoclonal antibody medication that is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease. The drug is being developed by Chugai Pharmaceutical, a subsidiary of Roche.
Immunogenn/a
Other NamesAnti-IL6R Recombinant Antibody, Research Grade Satralizumab, Anti-Human IL6R Recombinant Antibody(Satralizumab), SA-237, Antibody Drug Analogues, Monoclonal Antibody, YR1396, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1535963-91-7
Catalog #YR1396
Priceplease inquire
Order / More InfoIL6R, Human (Satralizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.